ATE511501T1 - Übergangsmetallkatalysierte synthese von 2h- indazolen - Google Patents

Übergangsmetallkatalysierte synthese von 2h- indazolen

Info

Publication number
ATE511501T1
ATE511501T1 AT08759156T AT08759156T ATE511501T1 AT E511501 T1 ATE511501 T1 AT E511501T1 AT 08759156 T AT08759156 T AT 08759156T AT 08759156 T AT08759156 T AT 08759156T AT E511501 T1 ATE511501 T1 AT E511501T1
Authority
AT
Austria
Prior art keywords
indazoles
transition metal
metal catalyzed
catalyzed synthesis
phenylacetylenes
Prior art date
Application number
AT08759156T
Other languages
English (en)
Inventor
Nis Halland
Marc Nazare
Andreas Lindenschmidt
Jorge Alonso
Kyek Omar R
Matthias Urmann
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE511501T1 publication Critical patent/ATE511501T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Catalysts (AREA)
AT08759156T 2007-06-26 2008-06-11 Übergangsmetallkatalysierte synthese von 2h- indazolen ATE511501T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07290799 2007-06-26
PCT/EP2008/004637 WO2009000411A1 (en) 2007-06-26 2008-06-11 A transition metal catalyzed synthesis of 2h-indazoles

Publications (1)

Publication Number Publication Date
ATE511501T1 true ATE511501T1 (de) 2011-06-15

Family

ID=38577414

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08759156T ATE511501T1 (de) 2007-06-26 2008-06-11 Übergangsmetallkatalysierte synthese von 2h- indazolen

Country Status (12)

Country Link
US (1) US8283476B2 (de)
EP (1) EP2170833B1 (de)
JP (1) JP5250029B2 (de)
KR (1) KR20100024963A (de)
CN (1) CN101687809A (de)
AT (1) ATE511501T1 (de)
AU (1) AU2008267442A1 (de)
BR (1) BRPI0813870A2 (de)
CA (1) CA2693024A1 (de)
IL (1) IL202825A0 (de)
MX (1) MX2009014203A (de)
WO (1) WO2009000411A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2697203B1 (de) * 2011-04-13 2017-05-24 Merck Sharp & Dohme Corporation Mineralkortikoid-rezeptorantagonisten
WO2014068988A1 (en) * 2012-10-31 2014-05-08 Raqualia Pharma Inc. Pyrazolopyridine derivatives as ttx-s blockers
CN103232462B (zh) * 2013-05-13 2016-03-02 湖北科技学院 香豆素-吡咯类化合物的合成方法
MX2017011579A (es) * 2015-03-12 2018-03-15 Du Pont Pesticidas de tipo azol bicíclicos sustituidos con un heterociclo.
KR102095007B1 (ko) * 2016-02-12 2020-03-30 주식회사 엘지화학 신규한 리간드 화합물 및 전이금속 화합물의 제조방법
KR101931234B1 (ko) 2016-02-12 2018-12-21 주식회사 엘지화학 신규한 리간드 화합물 및 전이금속 화합물
WO2017138783A1 (ko) * 2016-02-12 2017-08-17 주식회사 엘지화학 신규한 리간드 화합물 및 전이금속 화합물
KR102038977B1 (ko) * 2016-12-30 2019-11-01 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 신규한 시클로펜타[b]티오펜일 전이금속 화합물, 이를 포함하는 전이금속 촉매 조성물, 및 이를 이용한 에틸렌 단독중합체 또는 에틸렌과 α-올레핀의 공중합체의 제조방법
CN112533923B (zh) 2018-06-04 2024-07-09 爱克思科技有限公司 作为腺苷受体拮抗剂的吡唑并嘧啶化合物
CN110317204B (zh) * 2019-08-02 2022-02-08 安徽农业大学 吡唑并嘧啶酮类衍生物及其制备方法和应用
CN113698349B (zh) * 2021-09-02 2023-08-01 河南师范大学 一种2-(2-苯基-2h-吲唑-3-基)乙酸酯类化合物的水相光催化制备方法
CN114920699B (zh) * 2022-05-31 2024-03-19 甘肃皓天科技股份有限公司 一种制备6-氯-2-甲基-2h-吲唑-5-胺的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4647780B2 (ja) * 1998-02-26 2011-03-09 マサチューセッツ インスティテュート オブ テクノロジー ヒドラジン、ヒドラゾン、ヒドロキシルアミンおよびオキシムの金属−触媒アリール化およびビニル化

Also Published As

Publication number Publication date
US20100234601A1 (en) 2010-09-16
EP2170833A1 (de) 2010-04-07
WO2009000411A1 (en) 2008-12-31
BRPI0813870A2 (pt) 2015-01-06
IL202825A0 (en) 2010-06-30
JP2010531311A (ja) 2010-09-24
KR20100024963A (ko) 2010-03-08
US8283476B2 (en) 2012-10-09
MX2009014203A (es) 2010-01-28
CA2693024A1 (en) 2008-12-31
AU2008267442A1 (en) 2008-12-31
CN101687809A (zh) 2010-03-31
JP5250029B2 (ja) 2013-07-31
EP2170833B1 (de) 2011-06-01

Similar Documents

Publication Publication Date Title
ATE511501T1 (de) Übergangsmetallkatalysierte synthese von 2h- indazolen
IL202823A0 (en) A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
WO2007105058A8 (en) Pyrazole compounds
MX2010009416A (es) Compuestos heterociclicos como inhibidores de cxcr2.
ATE537142T1 (de) Übergangsmetallkatalysierte synthese von n- aminoindolen
WO2006092213A8 (de) Pyrazolylcarboxanilide
TW200720271A (en) DNA-PK inhibitors
MX2009009540A (es) Inhibidores de metaloproteasa que contienen una porcion heterociclica.
BRPI0813273A2 (pt) Síntese catalisada por metal regiosseletivo de benzimidazóis e azabenzimidazóis anelados
WO2008063781A3 (en) Chemical compounds as cannabinoid receptor ligands
UA109775C2 (xx) N-вмісні гетероарильні похідні як інгібітори jak3-кінази
MX2010002243A (es) Derivados fungicidas de 2-alquiltio-2-quinoliniloxi-acetamida.
MX2010002244A (es) Nuevos fungicidas.
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
TW200637837A (en) Fungicides
TNSN06405A1 (en) Quinazolinone derivatives useful as vanilloid antagonistes
AU2010332955A8 (en) 3,4,4A,10B-tetrahydro-1H-thiopyrano-[4, 3-c] isoquinoline derivatives
MX2009012374A (es) Compuestos novedosos como ligandos del receptor de canabinoides.
GB0508318D0 (en) Organic compounds
TW200638930A (en) Acetylene derivatives
ZA200801875B (en) Isoquinolines as IGF-IR inhibitors
TW200640912A (en) Novel processes for the preparation of a 2H-chromene
WO2006017054A3 (en) Tricyclic-heteroaryl compounds useful as kinase inhibitors
GB0508314D0 (en) Organic compounds
BRPI0812829A2 (pt) Processo para o acoplamento catalisado por paládio de alcinas terminais com tosilatos de arila

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties